InvestSMART
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Managed Funds
  5. SGH Medical Technology - Managed fund profile

SGH Medical Technology - Managed Fund

Fund Objective
To provide long-term capital growth by investing in a portfolio of medical technology companies where innovation plays a crucial role in improving global health and economic outcomes. This includes biotechnology, pharmaceuticals, medical devices & equipment, medical data, information technology (e-health), and robotics.
Fund Strategy
The investment manager seeks to achieve long-term capital growth by focusing stock selection on: 1. Share valuation 2. Company management and industry structure 3. Behavioural factors to determine investment-timing It is intended that the investment portfolio will consist of 40 to 60 companies split between: Mature Growth, Developing Growth, and Seed.

Fund Performance Comparison

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.

{{ fund.name }}
Peers
Benchmark ({{ fund.benchmark.name }})
{{ fund.model.name }}
The performance of the peers is calculated as the total of the performance for each time period for all the funds in the peer group, divided by the number of funds in the peer group.
grow your money
Grow your money, not your fees
It's fees rather than returns that make the biggest difference to your investment's compounding returns.
Free Fees Report
investing
Investing made simple
Our professionally-tailored investment portfolios consistently beat most of our peers.
Free investor guide
Grow your money, not your fees
It's fees rather than returns that make the biggest difference to your investment's compounding returns. Free Fees Report
Investing made simple
Our professionally-tailored investment portfolios consistently beat most of our peers. Free investor guide

Fees Comparison

{{ fund.mer | number:2 }}
% p.a.
{{ fund.name }}
{{ modelPortfolio.mer * 100 | number:2 }}
% p.a.
{{ modelPortfolio.name }}
{{ fund.benchmark.peers.mer * 100 | number:2 }}
% p.a.
Average of peers ({{ fund.benchmark.peers.peerCount }})
NOTE: Fee data has been provided by Morningstar, it may not include all costs being charged on your investment such as platform and adviser fees. You should check your fund manager or adviser statements to find out the exact fees you are being charged. Peers are funds that use the same benchmark in the Morningstar database.
Upsell Banner

Fund performance

  1M 3M 6M 1Y p.a. 2Y p.a. 3Y p.a. 5Y p.a. 10Y p.a.
Total return -3.52% -2.94% -0.14% 8.05% 5.27% -4.76% -% -%
Growth return -3.52% -2.94% -0.14% 8.05% 5.27% -4.76% -% -%
Income return 0% 0% 0% 0% 0% 0% -% -%
Market index (S&P/ASX 200 TR AUD)
Total return -3.15% -0.8% 6.93% 11.44% 11.93% 7.41% 8.06% 8.51%
As at 31 Dec 2024. Returns for periods greater than 1 year are annualised. All figures are percentages.

Asset Allocation

No asset allocation data available.
Average Allocation of Peers
Australian Equities
93.80%
International Equities
4.16%
Cash
-0.44%
Property
2.10%
Fixed Interest
0.40%
Alternatives
-0.02%

General Information

Fund Details
Type Description
SGH Medical Technology
Equity Trustees Ltd
ETL2825AU
Equity Australia Other
Not Rated
Investment Fund
30 Jun 2021
$7.79 million (as at 30 Jan 2025)
$0.9046 (as at 30 Jan 2025)
$0.8982 (as at 30 Jan 2025)
Open
Offer information
Type Description
MER 1.74% (as at 18 Feb 2024)
Indirect Cost Ratio (ICR) 1.33% (as at 30 Jun 2023)
Performance fee (not included in ICR) 0
Minimum initial investment $20,000
Minimum additional investments $5,000.00

FAQs about the SGH Medical Technology

The objective of the SGH Medical Technology managed fund is To provide long-term capital growth by investing in a portfolio of medical technology companies where innovation plays a crucial role in improving global health and economic outcomes. This includes biotechnology, pharmaceuticals, medical devices & equipment, medical data, information technology (e-health), and robotics.

The strategy of the SGH Medical Technology managed fund is The investment manager seeks to achieve long-term capital growth by focusing stock selection on: 1. Share valuation 2. Company management and industry structure 3. Behavioural factors to determine investment-timing It is intended that the investment portfolio will consist of 40 to 60 companies split between: Mature Growth, Developing Growth, and Seed.

The APIR code of the SGH Medical Technology managed fund is ETL2825AU.

SGH Medical Technology’s total return last month was -3.52%. This was made up of a growth return of -3.52% and an income return of 0%. These returns were calculated as at 31 Dec 2024.

SGH Medical Technology’s total return for the last three months was -2.94%. This was made up of a growth return of -2.94% and an income return of 0%%. These returns were calculated as at 31 Dec 2024.

SGH Medical Technology’s one-year total return is 8.05%. This was made up of a growth return of 8.05% and an income return of 0%. These returns were calculated as at 31 Dec 2024.

SGH Medical Technology’s one-year total return is -4.76%. This was made up of a growth return of -4.76% and an income return of 0%. These returns were calculated as at 31 Dec 2024.

The asset allocation of the SGH Medical Technology managed fund is :

Australian Equities
100%
International Equities
0%
Cash
0%
Property
0%
Fixed Interest
0%
Alternatives
0%

The Responsible Entity for the SGH Medical Technology managed fund is Equity Trustees Ltd.

The SGH Medical Technology managed fund belongs to the Equity Australia Other sector/asset class.

As at 30 Jan 2025, the size of the SGH Medical Technology managed fund was $7.79 million.

The SGH Medical Technology managed fund has an inception date of 30 Jun 2021.

The current entry price of the SGH Medical Technology managed fund is $0.9046 per unit and the current exit price is $0.8982 per unit (as at 30 Jan 2025).

The current exit price of the SGH Medical Technology managed fund is $0.8982 per unit and the current entry price is $0.9046 per unit (as at 30 Jan 2025).

The minimum initial investment amount for the SGH Medical Technology managed fund is $20,000. Minimum additional investment is $5000.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.